hydroxyproline has been researched along with ursodeoxycholic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcigir, G; Ates, Y; Comert, B; Isik, AT; Mas, MR; Mas, N; Serdar, M; Tasci, I; Vural, SA | 1 |
| Chen, L; Chen, XZ; Wu, PB; Ye, HL; Zhang, G; Zhang, JW | 1 |
2 other study(ies) available for hydroxyproline and ursodeoxycholic acid
| Article | Year |
|---|---|
Rat liver fibrosis regresses better with pegylated interferon alpha2b and ursodeoxycholic acid treatments than spontaneous recovery.
Topics: Actins; Animals; Antiviral Agents; Apoptosis; Cholagogues and Choleretics; Collagenases; Drug Therapy, Combination; Hydroxyproline; In Situ Nick-End Labeling; Interferon alpha-2; Interferon-alpha; Kupffer Cells; Liver Cirrhosis, Experimental; Male; Matrix Metalloproteinase 13; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Recovery of Function; Tissue Inhibitor of Metalloproteinase-1; Ursodeoxycholic Acid | 2006 |
Ursodeoxycholic acid alleviates experimental liver fibrosis involving inhibition of autophagy.
Topics: Animals; Autophagy; Blotting, Western; Cell Line; Disease Models, Animal; Humans; Hydroxychloroquine; Hydroxyproline; Liver Cirrhosis; Male; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta1; Ursodeoxycholic Acid | 2020 |